Antagonists of the human CCR5 receptor as anti-HIV-1 agents.: Part 2:: Structure-activity relationships for substituted 2-aryl-1-[N-(methyl)-N-(phenylsulfonyl) amino]-4-(piperidin-1-yl)butanes

被引：72
|
作者：
Finke, PE
Meurer, LC
Oates, B
Mills, SG
MacCoss, M
Malkowitz, L
Springer, MS
Daugherty, BL
Gould, SL
DeMartino, JA
Siciliano, SJ
Carella, A
Carver, G
Holmes, K
Danzeisen, R
Hazuda, D
Kessler, J
Lineberger, J
Miller, M
Schleif, WA
Emini, EA
机构：
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Immunol Res, Rahway, NJ 07065 USA
[3] Merck Res Labs, Dept Antiviral Res, W Point, PA 19486 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2001年 / 11卷 / 02期
关键词：
D O I：
10.1016/S0960-894X(00)00639-9
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
(2S)-2-(3,4-Dichlorophenyl)-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-[spiro(2,3-dihydrobenzthiophene-3,4'-piperidin-1'-yl)]butane S-oxide (3) has been identified as a potent CCR5 antagonist lead structure having an IC50 = 35 nM. Herein, we describe the structure-activity relationship studies directed toward the requirement for and optimization of the C-2 phenyl fragment. The phenyl was found to be important for CCR5 antagonism and substitution was limited to small moieties at the 3-position (13 and 16. X=H, 3-F, 3-Cl, 3-Me). (C) 2001 Published by Elsevier Science Ltd.
引用
收藏
页码：265 / 270
页数：6
相关论文
共 50 条
  • [21] Discovery of N-benzyl-N′-(4-pipyridinyl)urea CCR5 antagonists as anti-HIV-1 agents (II): Modification of the acyl portion
    Duan, Maosheng
    Peckham, Jennifer
    Edelstein, Mark
    Ferris, Robert
    Kazmierski, Wieslaw M.
    Spaltenstein, Andrew
    Wheelan, Pat
    Xiong, Zhiping
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (24) : 7401 - 7404
  • [22] N-(2-{[5-Bromo-2-(piperidin-1-yl)-pyrimidin-4-yl]sulfanyl}-4-methoxy-phenyl)-4-methylbenzenesulfonamide
    Kumar, Mohan
    Mallesha, L.
    Sridhar, M. A.
    Kapoor, Kamini
    Gupta, Vivek K.
    Kant, Rajni
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O2831 - +
  • [23] Crystal structure and Hirshfeld surface analysis of N-(4-nitrophenyl)-2-(piperidin-1-yl)acetamide (lidocaine analogue)
    Maimoune, Imane
    Kariuki, Benson M.
    Allah, Abderrazzak El Moutaouakil Ala
    Nchioua, Intissar
    Alsubari, Abdulsalam
    Mague, Joel T.
    Zarrouk, Abdelkader
    Ramli, Youssef
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2025, 81 : 69 - +
  • [24] Synthesis and structure-activity relationships of N-{1-[(6-fluoro-2-naphthyl)methyllpiperidin-4-yl}benzamide derivatives as novel CCR3 antagonists
    Sato, Ippei
    Morihira, Koichiro
    Inami, Hiroshi
    Kubota, Hirokazu
    Morokata, Tatsuaki
    Suzuki, Keiko
    Hamada, Noritaka
    Iura, Yosuke
    Nitta, Aiko
    Imaoka, Takayuki
    Takahashi, Toshiya
    Takeuchi, Makoto
    Ohta, Mitsuaki
    Tsukamoto, Shin-Ichi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (01) : 144 - 156
  • [25] (2E,4E)-N-(4-(1H-indol-3-yl)piperidin-1-yl)alkyl-5-(substituted phenyl)-2,4-pentadienamides as antiallergic agents with antihistaminic and anti slow-reacting substance (SRS) activities
    Shigenaga, S
    Manabe, T
    Matsuda, H
    Fujii, T
    Matsuo, M
    ARCHIV DER PHARMAZIE, 1996, 329 (01) : 3 - 10
  • [26] Neuronal N-type calcium channel blocker:: Structure-activity relationship of a series of (S)-2-amino-1-(4-[(4-benzyloxy-phenyl)-(3-methyl-but-2-enyl)-amino]-piperidin-1-yl) 4-methyl-pentan-1-one analogs.
    Hu, LY
    Ryder, TR
    Rafferty, MF
    Siebers, KM
    Geer, JJ
    Lotarski, SM
    Rock, DM
    Stoehr, SJ
    Taylor, CP
    Weber, ML
    Miljanich, GP
    Millerman, E
    Szoke, BG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U48 - U48
  • [27] Structure-activity relationships of novel anti-malarial agents.: Part 4:: N-(3-benzoyl-4-tolylacetylaminophenyl)-3-(5-aryl-2-furyl)acrylic acid amides
    Wiesner, J
    Mitsch, A
    Wissner, P
    Krämer, O
    Jomaa, H
    Schlitzer, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (19) : 2681 - 2683
  • [28] SYNTHESIS AND ACHE ACTIVITY OF 2-[(1-ARYL-1H-TETRAZOL-5-YL)THIO]-N-([(SUBSTITUTED PHENYL)AMINO]CARBONYL)-ACETAMIDES
    SENGUPTA, AK
    BHATTACHARYA, T
    RASTOGI, A
    INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 1985, 24 (05): : 578 - 579
  • [29] N-(2-{[5-Bromo-2-(piperidin-1-yl)pyrimidin-4-yl] sulfanyl}-4-methoxyphenyl)-2,4,6-trimethylbenzene-sulfonamide
    Kumar, Mohan
    Mallesha, L.
    Sridhar, M. A.
    Kapoor, Kamini
    Gupta, Vivek K.
    Kant, Rajni
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O2767 - +
  • [30] Molecular interaction of the antagonist N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor
    Shim, JY
    Welsh, WJ
    Cartier, E
    Edwards, JL
    Howlett, AC
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (07) : 1447 - 1459
12345